Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?

Diabetes Res Clin Pract. 2024 Dec 26:219:111979. doi: 10.1016/j.diabres.2024.111979. Online ahead of print.

Authors

Neale Cohen¹, Asher Yeung², Alicia Jenkins²

Affiliations

¹ Baker Heart and Diabetes Institute, Australia. Electronic address: [email protected].
² Baker Heart and Diabetes Institute, Australia; Chinese University of Hong Kong, Hong Kong.

PMID: 39732202
DOI: 10.1016/j.diabres.2024.111979

No abstract available

Publication types

Letter